Medical Properties Trust (MPW) CFO receives performance and restricted stock grants

Rhea-AI Filing Summary

Medical Properties Trust executive Steven R. Hamner, Executive Vice President and CFO, reported equity award activity in the company’s common stock. On January 8, 2026, he was granted 509,124 shares tied to performance goals for debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028, and 549,854 restricted shares that will vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 67,265 shares were withheld at $5.04 per share to satisfy tax obligations upon vesting of restricted stock, which is described as not constituting a sale. After these transactions, Hamner directly beneficially owned 3,889,568 shares of Medical Properties Trust common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAMNER R STEVEN

(Last) (First) (Middle)

1000 URBAN CENTER DRIVE

SUITE 501

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	01/08/2026		A		509,124(1)	A	$0	3,406,979(2)	D
Common stock, par value $0.001	01/08/2026		A		549,854(3)	A	$0	3,956,833	D
Common stock, par value $0.001	01/09/2026		F		67,265(4)	D	$5.04	3,889,568	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds and further adjusted pursuant to modifier provisions in the award that are based on the Company's total return to shareholders.

2. The total amount of securities beneficially owned following the reported transaction includes a reduction of shares that were forfeited due to only partially satisfying the performance thresholds established as part of the 2023 Performance Share Award.

3. Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

4. Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

	W. Zachary Riddle, by power of attorney	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did MPW CFO Steven R. Hamner report on this Form 4?

Steven R. Hamner, Executive Vice President and CFO of Medical Properties Trust (MPW), reported three transactions in common stock: two equity awards granted on January 8, 2026, and a share withholding for taxes on January 9, 2026.

How many performance-based MPW shares were granted to Steven R. Hamner and how are they earned?

Hamner received 509,124 performance-based shares. These may be earned based on specific performance thresholds related to the company’s overall debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028, with up to one third tied to 2026 performance and further adjustment based on total shareholder return.

What time-based restricted stock did the MPW CFO receive and what is the vesting schedule?

Hamner was granted 549,854 restricted shares of Medical Properties Trust common stock. These shares vest ratably at the beginning of each of 12 calendar quarters, starting on April 1, 2026, meaning a portion becomes unrestricted at the start of each quarter over three years.

Were any MPW shares sold by the CFO in this Form 4 filing?

The filing shows 67,265 shares with transaction code F at $5.04 per share on January 9, 2026, but a footnote explains this represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock and does not constitute a sale transaction.

How many MPW shares does Steven R. Hamner own after these transactions?

Following the reported transactions, Hamner directly beneficially owned 3,889,568 shares of Medical Properties Trust common stock.

How did prior performance awards affect the MPW CFO’s total beneficial ownership?

A footnote states that the total securities beneficially owned after the transactions reflect a reduction of shares forfeited because performance thresholds for the 2023 Performance Share Award were only partially met.